USPTO Says VirnetX Can't Get Arthrex Do-Over On Network IP

By Tiffany Hu (January 14, 2021, 5:58 PM EST) -- The U.S. Patent and Trademark Office told the Federal Circuit Wednesday that VirnetX should not be able to invoke Arthrex to get rehearings on Patent Trial and Appeal Board rulings that struck down part of two network security patents involved in a $502.8 million verdict against Apple....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!